Remifentanil Hydrochloride Injection, Powder, Lyophilized, For Solution
Product Images NDC 63323-725

10 FDA label images from Fresenius Kabi Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Remifentanil Hydrochloride (NDC 63323-725). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Rem02 0004 01)

Chemical Structure (Rem02 0004 01)
Chemical structure diagram of Remifentanil Hydrochloride showing its molecular components and arrangement, including a cyclohexane ring, ester groups, and aromatic ring.*
FDA Label Image

Figure 1 (Rem02 0004 02)

Figure 1 (Rem02 0004 02)
Line graph comparing minute ventilation (% of baseline) over time (minutes) for Remifentanil Hydrochloride and Alfentanil. The x-axis shows time from -30 to 270 minutes, divided into 'During Infusion' and 'Post Infusion' phases. Data points with error bars illustrate ventilation changes in subjects receiving each drug.*
FDA Label Image

Figure 2 (Rem02 0004 03)

Figure 2 (Rem02 0004 03)
A line graph showing the mean concentration of Remifentanil Hydrochloride and Alfentanil in serum over time (minutes). The y-axis is labeled as mean serum concentration (ng/mL) on a logarithmic scale, and the x-axis as time in minutes. Two curves represent Remifentanil HCl at 0.05 mcg/kg/min and Alfentanil at 0.5 mcg/kg/min, with data points and error bars illustrating variability.*
FDA Label Image

10 (Rem02 0004 10)

FDA Label Image

Remif-label-01.jpg (Remif Label 01)

Remif-label-01.jpg (Remif Label 01)
Label for Remifentanil Hydrochloride injection powder, lyophilized, for solution, 1 mg per vial. The label states the product is equivalent to 1 mg of remifentanil and is for intravenous use only. It must be reconstituted and diluted prior to use. The labeler is Fresenius Kabi USA, LLC, Lake Zurich, IL.*
FDA Label Image

Remif-label-02.jpg (Remif Label 02)

Remif-label-02.jpg (Remif Label 02)
Remifentanil Hydrochloride for Injection 1 mg per vial lyophilized powder for intravenous use, supplied as 10 single-dose vials of 1 mg each. The label includes instructions for reconstitution to achieve 1 mg/mL concentration and notes on storage and dosage. Manufactured by Fresenius Kabi USA, LLC, Lake Zurich, IL.*
FDA Label Image

Remif-label-03.jpg (Remif Label 03)

Remif-label-03.jpg (Remif Label 03)
Label for Remifentanil Hydrochloride Injection, powder, lyophilized, for solution, providing 2 mg per vial equivalent to 2 mg remifentanil. The vial is single dose for intravenous use only. Instructions include reconstitution and dilution before use, storage at 2° to 25°C, and a note that the container closure is not made with natural rubber latex. Labeler is Fresenius Kabi USA, LLC.*
FDA Label Image

Remif-label-04.jpg (Remif Label 04)

Remif-label-04.jpg (Remif Label 04)
Remifentanil Hydrochloride for Injection 2 mg per vial label. The lyophilized powder is for intravenous use, with each vial containing 2 mg equivalent of remifentanil. The label includes storage instructions (2° to 25°C), reconstitution directions, and inactive ingredients details. The product is supplied by Fresenius Kabi USA, LLC, Lake Zurich, IL, with a package of 10 single-dose vials.*
FDA Label Image

Remif-label-05.jpg (Remif Label 05)

Remif-label-05.jpg (Remif Label 05)
Label for Remifentanil Hydrochloride injection powder, lyophilized, with 5 mg per vial strength for intravenous use. The single-dose vial is sterile and requires reconstitution and dilution before administration. The label includes storage instructions (2° to 25°C), a barcode, and the manufacturer Fresenius Kabi USA, LLC.*
FDA Label Image

Remif-label-06.jpg (Remif Label 06)

Remif-label-06.jpg (Remif Label 06)
Label for Remifentanil Hydrochloride for Injection, 5 mg per vial, lyophilized powder for solution, for intravenous use. The package contains 10 single-dose vials, each equivalent to 5 mg of remifentanil. Label shows storage instructions, dilution directions, and contains the Fresenius Kabi USA logo and address in Lake Zurich, IL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.